Evaluating the effect of Venlafaxine on irritable bowel syndrome
Phase 3
- Conditions
- Irritable Bowel Syndrome.Irritable bowel syndrome
- Registration Number
- IRCT20181118041691N1
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Age between 18 to 65 years old
presence of moderate to severe Irritable Bowel Syndrome symptoms
having least educational level of writing and reading
lacking of major psychological diseases (eg, depression, bipolar or psychotic mood disorders and presence of suicidal thoughts or plans)
no history of administration of anti- depressant or anti-anxiolytic medications within two weeks prior to study initiation.
Exclusion Criteria
diagnosis of any other disease that inhibits patients to continue study
pregnancy
lactation
patient's reluctance of using medications
patient's reluctance of fulfilling questionnaires
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method